Mycophenolate Mofetil as Second Line Therapy in AIH?

[Guest guest]

In patients with autoimmune hepatitis, efficient

immunosuppressive therapy is essential to avoid progression to cirrhosis. There is no established second line therapy for patients

failing standard therapy with steroids and azathioprine. The aim of this study was to examine the possible role of mycophenolate mofetil (MMF) as

second line treatment of autoimmune hepatitis (AIH)………

http://www.peerview-institute.org/news/content.nsf/PaperFrameSet?OpenForm & pp=1 & id=9B7A45A40938478D85257490006CD23C & refid=2466 & specid=999 & newsid=852571020057CCF6852574E50029FF05 & locref=ntkwatch & u=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve & db=PubMed & dopt=Abstract & list_uids=18853972

Barb in Texas - Together in the Fight - Whatever it

Takes!

Son Ken (34) UC 91 PSC 99, LTX 6/21 & 6/30 2007

@ Baylor/Dallas